Therapy News and Research

RSS

FDA approves Symbyax for treatment-resistant depression

The U.S. Food and Drug Administration (FDA) has approved a new indication for Symbyax (olanzapine and fluoxetine HCl capsules), Eli Lilly and Company has announced.

23 Mar 2009

Cubist Pharmaceuticals files patent infringement case against Teva Parenteral Medicines

Cubist Pharmaceuticals, Inc. has confirmed that it has filed a patent infringement lawsuit against Teva Parenteral Medicines, Inc. (TPM), Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd.

23 Mar 2009

Combination of very low LDL and normal systolic blood pressure attenuate coronary artery disease

New data published in the March 31, 2009, issue of the Journal of the American College of Cardiology show that patients with coronary artery disease (CAD) who achieve very low levels of low-density lipoprotein (LDL) cholesterol along with normal systolic blood pressure have the slowest progression of CAD.

23 Mar 2009

Exercise therapy benefits ICU patients

An exercise program developed at Wake Forest University Baptist Medical Center aimed at helping patients in the medical Intensive Care Unit (ICU) maintain physical conditioning is a featured 'Innovation Profile' on the Agency for Healthcare Research and Quality (AHRQ) Web site.

23 Mar 2009

Gold nanoparticles "cook" cancer cells

Researchers are describing a long-awaited advance toward applying the marvels of nanotechnology in the battle against cancer.

22 Mar 2009

How to increase the efficacy of local excision of rectal cancer

With the advancement of imaging techniques, the accuracy of preoperative rectal cancer staging has increased dramatically, and the preservation of physical function in rectal cancer patients has become a very important aim of research.

22 Mar 2009

Hollow gold nanospheres show promise in cancer therapy

A new metal nanostructure developed by researchers at the University of California, Santa Cruz, has already shown promise in cancer therapy studies and could be used for chemical and biological sensors and other applications as well.

22 Mar 2009

Therapeutic hypothermia is promising strategy to minimize tissue damage

Recognition of the benefits of cooling strategies to protect the brain and spinal cord after traumatic injury has led to a wealth of cutting edge research, prime examples of which are featured in a special hypothermia issue of Journal of Neurotrauma , a peer-reviewed journal published by Mary Ann Liebert, Inc.

20 Mar 2009

Insights into Parkinson's disease and deep-brain stimulation

About the only thing doctors have understood about deep-brain stimulation, which is widely used to treat Parkinson's disease symptoms, is that somehow it works for many patients.

20 Mar 2009

Scientists trial device to treat chemotherapy-related nausea

Trials to test acupressure wrist bands as a drug-free alternative for chemotherapy-related nausea are to take place at the University of Liverpool.

20 Mar 2009

Scientists closer to understanding how to control high blood sugar

Scientists are closer to understanding which proteins help control blood sugar, or glucose, during and after exercise.

20 Mar 2009

Discovery of genetic markers for aggressive head and neck cancer

Scientists at Albert Einstein College of Medicine of Yeshiva University have identified genetic markers that signal poor outcomes for patients with head and neck cancer.

20 Mar 2009

Researchers step toward a medicine that could actually stop the progress of Alzheimer's

VIB scientists connected to the K.U.Leuven have identified a molecule that can form the basis for a new therapy for Alzheimer's disease.

20 Mar 2009

Novel stimulation method sparks hope for Parkinson's disease sufferers

A novel stimulation method, the first potential therapy to target the spinal cord instead of the brain, may offer an effective and less invasive approach for Parkinson's disease treatment, according to pre-clinical data published in the journal Science by researchers at Duke University Medical Center.

20 Mar 2009

Research could lead to potential new drugs for treating asthma

The American Asthma Foundation announced that a significant research discovery they funded has been licensed by a leading biotech company.

20 Mar 2009

Study looks at maggot therapy on wound healing

Larval (maggot) therapy has similar health benefits and costs compared with a standard treatment for leg ulcers, find two studies published on bmj.com.

20 Mar 2009

Gleevec reduces risk of cancer returning in patients with life-threatening gastrointestinal stromal tumors

Data published online and in an upcoming print issue of The Lancet show that Gleevec (imatinib mesylate) tablets, when taken after surgery, substantially reduces the rate of recurrence of Kit-positive gastrointestinal stromal tumors (GIST) compared with placebo.

20 Mar 2009